PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 132 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $17,446,000 | -5.0% | 180,000 | -10.0% | 2.38% | +2.2% |
| Q2 2014 | $18,372,000 | +31.2% | 200,000 | 0.0% | 2.33% | +50.1% |
| Q1 2014 | $13,998,000 | -16.4% | 200,000 | -31.3% | 1.55% | -13.6% |
| Q4 2013 | $16,735,000 | +2.0% | 291,095 | -14.7% | 1.79% | -10.9% |
| Q3 2013 | $16,405,000 | +13.2% | 341,139 | -31.7% | 2.01% | +3.0% |
| Q2 2013 | $14,495,000 | – | 499,829 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |